November 30, 2023 Florida Medical Clinic Owner and Pharmacy Technician Sentenced to Prison in Clinical Trial Fraud Scheme
Big Pharma bets on AI to speed up clinical trials By Natalie Grover and Martin Coulter LONDON (Reuters) – Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test…
Two Clinical Labs and Their Owners Agree to Pay $5.7 Million to Resolve False Claims and Kickback Allegations
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL’s International Liver Congress™ 2022
Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English
Jubilant Therapeutics Inc. annonce le développement d’inhibiteurs de PD-L1 à petite molécule, disponibles par voie orale et pénétrant dans le cerveau, lors de la réunion annuelle 2022 de l’American Society of Clinical Oncology (ASCO) France – Français USA – English Deutschland – Deutsch
Jubilant Therapeutics Inc. berichtet auf der Jahrestagung 2022 der American Society of Clinical Oncology (ASCO) über die Entwicklung oral verfügbarer und ins Gehirn eindringender niedermolekularer PD-L1-Inhibitoren Deutschland – Deutsch USA – English France – Français
Androvia LifeSciences Presented Data, Providing Scientific Insights that Support Clinical Utility of Cap-Score™, a Validated and Consistent Measure of Fertility
Local/N.J. Doctor Selected as one of 30 members nationwide to the athenahealth 2022 Clinical Advisory Board Dr. Dan Fabius, Consensus Health Chief Medical Informatics Officer will collaborate with the athenahealth product team
Mitsubishi Tanabe Pharma America Highlights ALS Research at 2022 MDA Clinical & Scientific Conference